Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2014

Feb 25, 2014

30597_dirs_2014-02-25_5ffa06fa-dbd5-47dc-bc3d-9f66b2da918a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2014-02-22

Reporting Person: LIDGARD GRAHAM PETER (Sr. VP, Chief Science Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-22 Common Stock M 7225 Acquired 109374 Direct
2014-02-24 Common Stock S 3160 $14.07 Disposed 106214 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-24 Stock Option (right to buy) $13.96 A 47000 Acquired 2024-02-24 Common Stock (47000) Direct
2014-02-24 Restricted Stock Units $ A 33000 Acquired Common Stock (33000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 11396 Indirect

Footnotes

F1: Represents shares of common stock received upon vesting of a restricted stock unit award.

F2: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain shares of restricted stock on February 22, 2014.

F3: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date.

F4: Each restricted stock unit represents a contingent right to receive one share of common stock.

F5: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.